nuvrumetinib   Click here for help

GtoPdb Ligand ID: 14623

Synonyms: Compound 1 [WO2025147497] | compound 7 [PMID: 28011205]
Compound class: Synthetic organic
Comment: Nuvrumetinib is the INN for a mitogen-activated protein kinase (MEK) 1/2 inhibitor, with antineoplastic potential [2]. Structurally it is a macrocyclic molecule. It acts as an allosteric inhibitor, that is one of the compounds claimed in Pasithea Therapeutics' patent WO2025147497A1 [1]. Nuvrumetinib is likely the INN for their lead inhibitor PAS-004.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 4
Rotatable bonds 2
Topological polar surface area 116.27
Molecular weight 570.32
XLogP 2.17
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=C(C=C(C(=C1)NC2=C3C(=CC(=C2F)F)OC[C@@]([H])([C@@]([H])(CC4(CC4)S(=O)(=O)N3)O)O)F)I
Isomeric SMILES [C@@]1([H])(O)COC=2C(NS(=O)(=O)C3(CC3)C[C@@]1([H])O)=C(NC=4C=CC(I)=CC4F)C(F)=C(F)C2
InChI InChI=1S/C19H18F3IN2O5S/c20-10-5-9(23)1-2-12(10)24-18-16(22)11(21)6-15-17(18)25-31(28,29)19(3-4-19)7-13(26)14(27)8-30-15/h1-2,5-6,13-14,24-27H,3-4,7-8H2/t13-,14+/m1/s1
InChI Key FENWEVRRFMFDBS-KGLIPLIRSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)